Back to Search Start Over

Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer – A prospective cohort analysis.

Authors :
Sommat, Kiattisa
Hussain, Ashik
Ong, Whee Sze
Yit, Nelson Ling Fung
Khoo, James Boon Kheng
Soong, Yoke Lim
Wee, Joseph Tien Seng
Fong, Kam Weng
Tan, Terence Wee Kiat
Source :
Radiotherapy & Oncology. Sep2019, Vol. 138, p149-157. 9p.
Publication Year :
2019

Abstract

• Significant proportion of patients still experienced long term xerostomia with IMRT. • Despite the use of IMRT, none of the patients met the recommended dose constraint of parotid glands. • Dose-effect relationships between xerostomia and the parotid glands were not observed in this study. • The incidence of physician-rated xerostomia was consistently lower than patient-reported xerostomia across all time points. • Sophisticated radiotherapy technique such as proton therapy may be able to better spare the salivary glands. To compare physician and patient reported xerostomia and correlate xerostomia with dosimetric and clinical parameters for nasopharyngeal cancer (NPC) patients treated with intensity modulated radiotherapy (IMRT) and chemotherapy. We analyzed the data of 172 patients with locally advanced NPC. Xerostomia was evaluated via physician-rated xerostomia based on RTOG morbidity score (E1), patient-rated dry mouth (E2) and patient-rated sticky saliva (E3) based on EORTC QLQ-HN35 questionnaire. Primary endpoint was the presence of moderate to severe xerostomia at 2-year after completion of IMRT. The levels of physician reported xerostomia (E1) were consistently lower than patient reported dry mouth (E2) over time. The incidence of patients with xerostomia at 3-month post RT was 58% based on E1, 70% based on E2, and 51% based on E3. The corresponding incidence rates at 2-year post RT was 26% (E1), 36% (E2) and 21% (E3). The incidence of patients with xerostomia at 1-year post RT was close to that at 2-year post RT for all the 3 endpoints. The average Dmean of parotid glands was 41.5 Gy (range: 31.0 Gy-65.9 Gy, median: 40.7 Gy). No dosimetric parameters were significantly associated with xerostomia. Significant proportion of patients still experienced long term xerostomia with IMRT. Dose-effect relationships between xerostomia and the parotid glands were not observed in this study. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01678140
Volume :
138
Database :
Academic Search Index
Journal :
Radiotherapy & Oncology
Publication Type :
Academic Journal
Accession number :
138202450
Full Text :
https://doi.org/10.1016/j.radonc.2019.05.023